Penthrox approved for sale in Taiwan
8 December 2016
ASX ANNOUNCEMENT
Penthrox approved for sale in Taiwan
Medical Developments International Limited (ASX: MVP) is delighted to announce it has received regulatory approval from the Taiwan Food and Drug Administration (TFDA) for Penthrox to be used for patients with trauma and associated pain and for the relief of pain in monitored conscious patients who require analgesia for surgical procedures.
For details relating to the full ASX release, please click on the following link: Penthrox-approved-for-sale-in-Taiwan